Artiklar

{{ window.visitor.ipAccess.corporateClient.name }}
Welcome to our Corporate client solution

Your IP is registered with the company mentioned above and provides access to Life Science Sweden.
Click here to go to sign-up

Sortering: Sida Sida av 1

Crispr-bolag pausar studier efter rapport om allvarliga biverkningar
Okt. 28
En allvarlig leverpåverkan hos en patient gör att amerikanska Intellia Therapeutics nu stoppar behandling och rekrytering i fas 3-studier med företagets genterapi.
Health politician Lina Nordquist: ”I find it hard to be idle”
Mar. 03
She is the pharmacist and researcher who grew tired of the breakthroughs that never materialised and knowledge that never seemed to reach patients, so she decided to make a change from within. Life Science Sweden meets Lina Nordquist, Member of Parliament for the Liberals and their spokesperson on healthcare policy, to have a conversation about reality, politics, and the need for writing.

Resultat per sida: Sida Sida av 1

BREAKING

{{ article.headline }}

0.111|instance-web01